161 related articles for article (PubMed ID: 29417935)
1. Hydroxysafflor-Yellow A Induces Human Gastric Carcinoma BGC-823 Cell Apoptosis by Activating Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
Liu L; Si N; Ma Y; Ge D; Yu X; Fan A; Wang X; Hu J; Wei P; Ma L; Chen Z; Zhang Q; Feng C
Med Sci Monit; 2018 Feb; 24():803-811. PubMed ID: 29417935
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
Su D; Lv C
Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
[TBL] [Abstract][Full Text] [Related]
3. Hydroxysafflor Yellow A Shows Protection against PPAR
Sun L; Xu YW; Han J; Xiao C; Cao SS; Liang H; Cheng Y
Oxid Med Cell Longev; 2018; 2018():9101740. PubMed ID: 30410641
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-κB signaling pathway in H22 tumor-bearing mice.
Yang F; Li J; Zhu J; Wang D; Chen S; Bai X
Eur J Pharmacol; 2015 May; 754():105-14. PubMed ID: 25720342
[TBL] [Abstract][Full Text] [Related]
5. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
6. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor yellow A attenuate lipopolysaccharide-induced endothelium inflammatory injury.
Jin M; Sun CY; Zang BX
Chin J Integr Med; 2016 Jan; 22(1):36-41. PubMed ID: 26015073
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.
Zhang J; Li J; Song H; Xiong Y; Liu D; Bai X
Biomed Pharmacother; 2019 Jan; 109():806-814. PubMed ID: 30551534
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer.
Wu N; Li J; Luo H; Wang D; Bai X
Biomed Pharmacother; 2021 Apr; 136():111227. PubMed ID: 33485070
[TBL] [Abstract][Full Text] [Related]
11. MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells.
Tang D; Huang T; Tian Q; Wang J
Drug Des Devel Ther; 2021; 15():1749-1763. PubMed ID: 33953544
[TBL] [Abstract][Full Text] [Related]
12. [Effects of hydroxy safflor yellow A on blood vessel and mRNA expression with VEGF and bFGF of transplantation tumor with gastric adenocarcinoma cell line BGC-823 in nude mice].
Xi S; Zhang Q; Xie H; Liu L; Liu C; Gao X; Zhang J; Wu L; Qian L; Deng X
Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):605-10. PubMed ID: 19526794
[TBL] [Abstract][Full Text] [Related]
13. Effects of hydroxy safflower yellow-A on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice.
Xi SY; Zhang Q; Liu CY; Xie H; Yue LF; Gao XM
J Tradit Chin Med; 2012 Jun; 32(2):243-8. PubMed ID: 22876451
[TBL] [Abstract][Full Text] [Related]
14. The Role of E-Cadherin/β-Catenin in Hydroxysafflor Yellow A Inhibiting Adhesion, Invasion, Migration and Lung Metastasis of Hepatoma Cells.
Ma L; Liu L; Ma Y; Xie H; Yu X; Wang X; Fan A; Ge D; Xu Y; Zhang Q; Song C
Biol Pharm Bull; 2017; 40(10):1706-1715. PubMed ID: 28966242
[TBL] [Abstract][Full Text] [Related]
15. Hormone-sensitive lipase is involved in the action of hydroxysafflor yellow A (HYSA) inhibiting adipogenesis of 3T3-L1cells.
Zhu HJ; Wang LJ; Wang XQ; Pan H; Li NS; Yang HB; Jin M; Zang BX; Gong FY
Fitoterapia; 2014 Mar; 93():182-8. PubMed ID: 24440907
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway.
Chen X; Wang Y; Zhang L; Gao Y
Cell Biochem Biophys; 2020 Dec; 78(4):511-520. PubMed ID: 32705535
[TBL] [Abstract][Full Text] [Related]
17. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro.
Li CC; Yang CZ; Li XM; Zhao XM; Zou Y; Fan L; Zhou L; Liu JC; Niu YC
Eur J Pharm Sci; 2012 Aug; 46(5):397-404. PubMed ID: 22449726
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
Yang YC; Tsao YP; Ho TC; Choung IP
Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Hydroxysafflor Yellow A on Nephropathy by Attenuating Oxidative Stress and Inhibiting Apoptosis in Induced Type 2 Diabetes in Rat.
Lee M; Zhao H; Liu X; Liu D; Chen J; Li Z; Chu S; Kou X; Liao S; Deng Y; Li H; Xie W
Oxid Med Cell Longev; 2020; 2020():7805393. PubMed ID: 32256962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
